Medical Writers News Hubb
Advertisement Banner
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home News

Integer to exhibit at NANS annual meeting

admin by admin
January 15, 2023
in News


Integer Holdings logo

Integer (NYSE:ITGR) announced that it plans to exhibit at the North American Neuromodulation Society (NANS) Annual Meeting this week.

Plano, Texas-based Integer’s showcase takes place at the meeting at Caesars Palace Convention Center in Las Vegas. It spans from Jan. 12 to Jan. 14.

The company, situated at booth #525, intends to offer information about its medical device manufacturing, designs nd development capabilities. These include implantable neuromodulation offerings following the acquisition of Oscor in December 2021, according to a news release.

Integer plans to unveil its latest innovations in neuromodulation. It said these technologies “enable the next-generation of miniaturized active implantable devices.”

Other offerings Integer will display include its new Xcellion Gen-3 fast-charge lithium-ion implantable battery technology. It features best-in-class battery runtime and full recharges in as little as 30 minutes, Integer said.

Michael Sanford, VP of commercialization, called the company “uniquely positioned” with broad expertise. This ranges from batteries to fully integrated implantable pulse generator systems, he said.

“Integer built its leadership position in active implantables by providing OEMs with innovative, development-ready technology solutions that can be customized for each application,” said Sanford. “The objective of our miniaturization effort is to create the next generation of differentiated platform technologies to accelerate and de-risk OEMs’ path to market for novel implantable medical devices.”



Source link

Previous Post

Researchers unveil new methods for DNA mosaic recognition

Next Post

COVID-19 vaccine hesitancy still remains even though acceptance rates have increased in 2022

Next Post

COVID-19 vaccine hesitancy still remains even though acceptance rates have increased in 2022

Recommended

Researchers develop scale to assess antibiotic resistance awareness among healthcare professionals

2 days ago

Micro Mold renovates for new 5-axis milling center

4 months ago

Research reveals pivotal role of C/EBPb in the development of alveolar macrophages

5 months ago

Grant And Manuscript Success Secrets Of Top Biomedical PIs

2 days ago

Almost a third of patients with chronic pain use cannabis

3 weeks ago

Exploring new therapeutic targets and biomarkers for neurodegenerative disorders

3 months ago

Medical-Writers-(-white-)

© 2022 Medical Writers News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Papers
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Papers
  • Contact

© 2022 Medical Writers News Hubb All rights reserved.